The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects - Concepedia

Concepedia

Publication | Closed Access

The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects

46

Citations

23

References

2014

Year

Marta Hamilton, Julie Wolf, Daniel W. Drolet, Scott Fettner, Ashok Rakhit, Karsten Witt, Bert L. Lum

Cancer Chemotherapy and Pharmacology

Healthy SubjectsErlotinib PharmacokineticsPharmacological StudyMedicinePrototypical Cyp3a4 InducerClinical PharmacologyPharmacotherapyPharmacologyPharmacokineticsDrug Resistance

References

	Year	Citations

Page 1